1-2 of 2
Jino Park, PhD
Close
Sort by
Journal Articles

Long-Term Follow-up Results: A Phase 2 Trial of Imatinib Mesylate As Maintenance Therapy for Patients with Newly Diagnosed c-Kit Positive Acute Myeloid Leukemia (AML)

Anjali S. Advani, MD, William Tse, MD FACP, Xuefei Jia, Paul Elson, PhD, Brenda Cooper, MD, Francis Ali-Osman, Jino Park, PhD, Arati V. Rao, MD, David A. Rizzieri, MD, Eunice S. Wang, MD, Claudiu V. Cotta, MD, Matt Kalaycio, MD, Ronald M. Sobecks, MD, Basel Rouphail, MD MBA, Jaroslaw P. Maciejewski, MD PhD, Jaime Fensterl, Laura Bailey, BS, Jennifer S. Carew, PhD, Bethany Foster, Mary Lynn Rush, Donna Adams, Elizabeth A. Griffiths, MD, Mikkael A. Sekeres, MD MS
Journal: Blood
Blood (2015) 126 (23): 2536.
https://doi.org/10.1182/blood.V126.23.2536.2536
Published: 2015
Journal Articles

A Phase 2 Trial of Imatinib Mesylate As Maintenance Therapy for Patients with Newly Diagnosed C-Kit Positive Acute Myeloid Leukemia (AML)

Anjali Advani, MD, Brenda Cooper, MD, Olumuyiwa Sowunmi, MD, Paul Elson, Francis Ali-Osman, DSc, Jino Park, PhD, Arati Rao, MD, David A. Rizzieri, MD, Eunice S. Wang, MD, Claudiu Cotta, MD, Mikkael A. Sekeres, MD, MS, Matt Kalaycio, MD, Ronald Sobecks, MD, Basel Rouphail, MD, Jaroslaw P. Maciejewski, MD, PhD, Randall Davis, Laura Bailey, Bethany Foster, Mary Lynn Rush, Donna Adams, RN, William Tse, MD
Journal: Blood
Blood (2012) 120 (21): 3597.
https://doi.org/10.1182/blood.V120.21.3597.3597
Published: 2012